Cargando…

Omacetaxine Mepesuccinate: A New Treatment Option for Patients With Chronic Myelogenous Leukemia

Detalles Bibliográficos
Autores principales: Kurtin, Sandra E., Matta, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093431/
https://www.ncbi.nlm.nih.gov/pubmed/25032006
_version_ 1782325727607128064
author Kurtin, Sandra E.
Matta, Lisa
author_facet Kurtin, Sandra E.
Matta, Lisa
author_sort Kurtin, Sandra E.
collection PubMed
description
format Online
Article
Text
id pubmed-4093431
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-40934312014-07-16 Omacetaxine Mepesuccinate: A New Treatment Option for Patients With Chronic Myelogenous Leukemia Kurtin, Sandra E. Matta, Lisa J Adv Pract Oncol Review Article Harborside Press 2013 2013-07-01 /pmc/articles/PMC4093431/ /pubmed/25032006 Text en Copyright © 2013, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Kurtin, Sandra E.
Matta, Lisa
Omacetaxine Mepesuccinate: A New Treatment Option for Patients With Chronic Myelogenous Leukemia
title Omacetaxine Mepesuccinate: A New Treatment Option for Patients With Chronic Myelogenous Leukemia
title_full Omacetaxine Mepesuccinate: A New Treatment Option for Patients With Chronic Myelogenous Leukemia
title_fullStr Omacetaxine Mepesuccinate: A New Treatment Option for Patients With Chronic Myelogenous Leukemia
title_full_unstemmed Omacetaxine Mepesuccinate: A New Treatment Option for Patients With Chronic Myelogenous Leukemia
title_short Omacetaxine Mepesuccinate: A New Treatment Option for Patients With Chronic Myelogenous Leukemia
title_sort omacetaxine mepesuccinate: a new treatment option for patients with chronic myelogenous leukemia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093431/
https://www.ncbi.nlm.nih.gov/pubmed/25032006
work_keys_str_mv AT kurtinsandrae omacetaxinemepesuccinateanewtreatmentoptionforpatientswithchronicmyelogenousleukemia
AT mattalisa omacetaxinemepesuccinateanewtreatmentoptionforpatientswithchronicmyelogenousleukemia